TNF and arthritic joint disease: Under certain conditions, such as treatment with anti-arthritis drugs e.g. Adalimumab, Etanercept or Infliximab, that are based on neutralization of TNF-α or its receptor, the dormant Mtb becomes metabolically active, resulting in active TB.